Picture of Appili Therapeutics logo

APLI Appili Therapeutics News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Appili Therapeutics Signed A Collaboration, Development And Supply Agreement With Dr. Reddy's Laboratories And Global Response Aid

Oct 30 (Reuters) - Appili Therapeutics Inc  APLI.TO :
    * APPILI THERAPEUTICS INC - SIGNED A COLLABORATION,
DEVELOPMENT
AND SUPPLY AGREEMENT WITH DR. REDDY'S LABORATORIES AND GLOBAL
RESPONSE AID
    * APPILI - AGREEMENTS TO ACCELERATE WORLDWIDE DEVELOPMENT,
COMMERCIALIZATION OF AVIGAN TABLETS FOR POTENTIAL TREATMENT AND
PREVENTION OF COVID-19
    * APPILI THERAPEUTICS INC - DR. REDDY'S AND GRA WILL
CONTINUE TO
BE RESPONSIBLE FOR RESEARCH AND DEVELOPMENT, COMMERCIALIZATION,
OF AVIGAN
    * APPILI - WILL BE RESPONSIBLE FOR US & CANADIAN CLINICAL
TRIALS
CONDUCTED & WILL RECEIVE PROFIT SHARE ON ALL US AND CANADIAN
SALES FOR A SPECIFIED TERM

Source text for Eikon:  ID:nBw5X7bGTa 
Further company coverage:  APLI.TO 

 ((Reuters.briefs@thomsonreuters.com;))

Recent news on Appili Therapeutics

See all news